Do You Qualify for Nourianz (Istradefylline) Coverage by Blue Cross Blue Shield of Michigan? Complete Decision Tree & Appeals Guide
Quick Answer: Getting Nourianz Covered by BCBS Michigan
You likely qualify for Nourianz (istradefylline) coverage if you're an adult with Parkinson's disease experiencing OFF episodes despite optimized levodopa/carbidopa therapy. BCBS Michigan typically requires prior authorization with documentation of failed alternative treatments. First step today: Check your plan's 2024 formulary for PA requirements, then gather your Parkinson's diagnosis records and prior therapy history. If denied, you have 180 days for internal appeals and 127 days for external review through Michigan DIFS. Success rates improve significantly with thorough documentation and specialist support.
Table of Contents
- How to Use This Decision Tree
- Eligibility Triage: Do You Qualify?
- If "Likely Eligible": Document Checklist
- If "Possibly Eligible": Tests & Timeline
- If "Not Yet": Alternatives & Exceptions
- If Denied: Appeal Path Chooser
- Visual Flowchart
- Resources & Forms
How to Use This Decision Tree
This guide helps you determine your likelihood of getting Nourianz (istradefylline) covered by Blue Cross Blue Shield of Michigan and provides specific next steps for each scenario. Nourianz is an adenosine A2A receptor antagonist approved for adults with Parkinson's disease experiencing "OFF" episodes while on levodopa/carbidopa.
Before you start, gather:
- Your BCBS Michigan ID card and group number
- Current medication list (especially levodopa dose and schedule)
- Recent neurology notes documenting OFF episodes
- List of previously tried Parkinson's medications
Eligibility Triage: Do You Qualify?
Work through these questions to determine your coverage likelihood:
✅ Likely Eligible (High Success Rate)
All of these apply:
- Age 18 or older with confirmed Parkinson's disease diagnosis
- Currently on stable levodopa/carbidopa for ≥4 weeks
- Documented OFF episodes (wearing-off, morning akinesia, unpredictable OFF time)
- Have tried and failed/cannot tolerate at least one alternative adjunct therapy:
- MAO-B inhibitor (rasagiline, selegiline, safinamide)
- COMT inhibitor (entacapone, opicapone)
- Dopamine agonist (ropinirole, pramipexole)
- Amantadine
- No severe liver disease (Child-Pugh Class C)
- Prescribed by or in consultation with a neurologist
⚠️ Possibly Eligible (Moderate Success Rate)
Some of these apply:
- Parkinson's diagnosis confirmed but limited documentation of OFF episodes
- On levodopa/carbidopa but haven't tried preferred alternative adjuncts
- Previous adjunct therapies discontinued for reasons other than failure/intolerance
- Mild-to-moderate liver impairment (requires dose adjustment)
- History of hallucinations or psychiatric symptoms (requires careful risk-benefit assessment)
❌ Not Yet Eligible (Low Success Rate Without Additional Steps)
Any of these apply:
- Not currently on levodopa/carbidopa
- No documented OFF episodes despite levodopa therapy
- Haven't tried any alternative adjunct therapies
- Severe liver impairment (Child-Pugh Class C)
- Active psychosis or uncontrolled psychiatric symptoms
- Parkinson's diagnosis not confirmed by movement disorder specialist
If "Likely Eligible": Document Checklist
Required Documentation for PA Submission
| Document Type | Specific Requirements | Where to Obtain |
|---|---|---|
| Diagnosis Confirmation | ICD-10 code G20 (Parkinson's disease), date of diagnosis, staging if available | Neurology records |
| Current Levodopa Regimen | Exact dose, frequency, duration of current regimen (≥4 weeks stability) | Prescription records |
| OFF Episode Documentation | Hours per day, timing relative to doses, functional impact on ADLs | Patient diary, neurology notes |
| Prior Therapy History | Drug names, doses, duration tried, reason for discontinuation | Medical records, pharmacy history |
| Prescriber Information | Neurologist or movement disorder specialist credentials | Provider license verification |
Submission Path
- Check formulary status: Access your 2024 BCBS Michigan formulary to confirm PA requirement
- Submit via provider portal: Use BCBS Michigan e-referrals system for fastest processing
- Expected timeline: 5-7 business days for standard PA, 72 hours for urgent requests
- Track status: Monitor through provider portal or call member services number on your ID card
Tip from Our Advocates: Patients with the strongest approvals include a detailed OFF episode diary covering 7-14 days, showing specific times and functional limitations. This concrete evidence often overcomes step therapy requirements when combined with clear documentation of why preferred alternatives aren't suitable.
If "Possibly Eligible": Tests & Timeline
Additional Documentation Needed
To strengthen your case:
- Quantify OFF episodes: Complete a 2-week diary tracking:
- Time of each levodopa dose
- Onset and duration of OFF periods
- Activities affected (walking, dressing, eating)
- Download OFF diary template from movement disorder resources
- Document alternative therapy trials: Request records showing:
- Specific medications tried (generic and brand names)
- Doses and duration of each trial
- Reason for discontinuation (side effects, inefficacy, contraindications)
- Specialist evaluation: If not already seeing one, request referral to:
- Neurologist specializing in movement disorders
- Assessment of motor fluctuations and treatment optimization
Timeline to Reapply
- 2-4 weeks: Gather additional documentation
- 4-6 weeks: Complete specialist evaluation if needed
- 6-8 weeks: Resubmit PA with comprehensive documentation
If "Not Yet": Alternatives & Exceptions
Alternative Treatments to Discuss
Before pursuing Nourianz, consider these evidence-based options:
| Treatment Category | Specific Options | Typical Use |
|---|---|---|
| MAO-B Inhibitors | Rasagiline, safinamide | First-line adjunct for OFF episodes |
| COMT Inhibitors | Entacapone, opicapone | End-of-dose wearing off |
| Dopamine Agonists | Ropinirole, pramipexole | Younger patients without cognitive concerns |
| Amantadine ER | Extended-release formulation | When dyskinesia is also present |
Preparing for Exception Requests
If alternatives are contraindicated or inappropriate:
- Document contraindications: Clear medical reasons why preferred therapies can't be used
- Gather supporting literature: FDA labeling, clinical guidelines supporting Nourianz as appropriate choice
- Specialist letter: Detailed medical necessity letter from movement disorder specialist
If Denied: Appeal Path Chooser
Level 1: Internal Appeal
Timeline: File within 180 days of denial notice Processing: 30 days for pre-service, 60 days for post-service How to file: BCBS Michigan Appeal Form
Required documents:
- Original denial letter
- Medical necessity letter from prescriber
- Clinical evidence supporting Nourianz use
- Documentation of failed alternative therapies
Peer-to-Peer Review Option
When to use: Before or during internal appeal process How to request: Call provider services number on ID card Timeline: Usually scheduled within 3-5 business days Participants: Your prescribing physician and BCBS medical director
Level 2: External Review (Michigan DIFS)
Timeline: File within 127 days of final internal denial Processing: Up to 60 days standard, 72 hours expedited Cost: Free to patients How to file: Michigan DIFS External Review Form
Expedited review criteria (72-hour decision):
- Serious jeopardy to health if delayed
- Physician letter supporting urgency
- Treatment needed for ongoing care
Note: Michigan's external review decisions are binding on BCBS Michigan. Recent data shows meaningful success rates for specialty drug appeals when supported by strong clinical evidence.
Visual Flowchart
Start: Need Nourianz Coverage
↓
Are you on levodopa/carbidopa with documented OFF episodes?
↓ YES ↓ NO
Have you tried alternative adjuncts? Document OFF episodes first
↓ YES ↓ NO Return to flowchart
Submit PA with Try preferred
failure docs alternatives first
↓ ↓
PA Decision If contraindicated,
↓ request exception
Approved ✓ ↓
↓ Denied
Denied ↓
↓ Internal Appeal (180 days)
Internal Appeal ↓
↓ Still Denied
External Review ↓
(DIFS - 127 days) External Review (DIFS)
Common Denial Reasons & How to Overturn
| Denial Reason | How to Overturn | Required Documentation |
|---|---|---|
| Step therapy not met | Document failure/contraindication to preferred alternatives | Pharmacy records, side effect notes, allergy documentation |
| Not medically necessary | Provide detailed clinical rationale | Specialist letter, OFF episode diary, functional assessments |
| Insufficient documentation | Submit complete medical records | Diagnosis confirmation, treatment history, current symptoms |
| Non-formulary | Request formulary exception | Comparative effectiveness evidence, cost-benefit analysis |
Coverage at a Glance
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| PA Required | Prior authorization needed before coverage | Plan formulary, member portal | BCBS Michigan PA Guidelines |
| Step Therapy | Must try preferred alternatives first | PA criteria document | Provider portal criteria |
| Specialist Required | Neurologist prescription preferred | PA submission requirements | Internal PA policy |
| Age Restriction | Adults 18+ only | FDA labeling requirement | Nourianz Prescribing Information |
Resources & Forms
BCBS Michigan Resources
Michigan State Resources
- DIFS External Review Process
- External Review Request Form
- DIFS Consumer Hotline: 877-999-6442
Clinical Resources
Frequently Asked Questions
How long does BCBS Michigan PA take for Nourianz? Standard processing is 5-7 business days. Urgent requests with physician support for medical urgency are processed within 72 hours.
What if Nourianz isn't on my formulary? Request a formulary exception with clinical justification. Include evidence that formulary alternatives are inappropriate or ineffective for your specific case.
Can I request an expedited appeal in Michigan? Yes. Michigan offers expedited external review (72-hour decision) when delay would seriously jeopardize health. Requires physician letter supporting urgency.
Does step therapy apply if I failed treatments outside Michigan? Yes. Documentation of failed therapies from any state is typically accepted if properly documented in medical records.
What counts as "failed" alternative therapy? Inadequate symptom control after adequate trial duration, intolerable side effects, or medical contraindications. Document specific reasons and timeframes.
About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that address payers' specific requirements. We've helped thousands of patients access necessary medications by providing the clinical documentation and procedural expertise needed for coverage approval.
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan terms and medical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance. For additional help with insurance appeals in Michigan, contact the Michigan Department of Insurance and Financial Services at 877-999-6442.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.